8-Hydroxyquinoline: A privileged structure with a broad-ranging pharmacological potential

MedChemComm

Volumn 6, Issue 1, 2015, Pages 61-74

  Song, Yu'Ning ^a   Xu, Hao ^b   Chen, Wenmin ^a   Zhan, Peng ^a   Liu, Xinyong ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARATE INHIBITOR; 2 OXOGLUTARIC ACID; 5 CARBOXY 8 HYDROXYQUINOLINE; 8 HYDROXY 2 QUINOLINECARBALDEHYDE; 8 HYDROXYQUINOLINE 2 CARBOXAMIDE; 8 QUINOLINOL; 8 QUINOLINOL DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIFUNGAL AGENT; ANTILEISHMANIAL AGENT; ANTINEOPLASTIC AGENT; ANTISCHISTOSOMAL AGENT; BOTULINUM NEUROTOXIN INHIBITOR; BOTULINUM TOXIN; CHOLINESTERASE INHIBITOR; CLIOQUINOL; IRON CHELATING AGENT; JLK 1472; JLK 1486; METALLOPROTEIN; MONOAMINE OXIDASE INHIBITOR; NITROXOLINE; NSC 3852; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; DRUG BINDING; DRUG EFFECT; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NEUROPROTECTION; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 84920380487     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c4md00284a     Document Type: Article

References (69)

1. R. W. DeSimone K. S. Currie S. A. Mitchell J. W. Darrow D. A. Pippin Privileged structures: applications in drug discovery Comb. Chem. High Throughput Screening 2004 7 5 473 494
2. C. D. Duarte E. J. Barreiro C. A. Fraga Privileged structures: a useful concept for the rational design of new lead drug candidates Mini-Rev. Med. Chem. 2007 7 11 1108 1119
3. P. Zhan X. Liu E. De Clercq Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives Curr. Med. Chem. 2008 15 15 1529 1540
4. P. Zhan X. Liu E. De Clercq Functional Roles of Azoles Motif in Anti-HIV Agents Curr. Med. Chem. 2011 18 1 29 46
5. P. Zhan D. Li J. Li X. Chen X. Liu Benzimidazole heterocycle as a privileged scaffold in antiviral agents Mini-Rev. Org. Chem. 2012 9 4 397 410
6. Y. Song P. Zhan Q. Zhang X. Liu Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry Curr. Pharm. Des. 2013 19 8 1528 1548
7. Y. Song P. Zhan X. Liu Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities Curr. Pharm. Des. 2013 19 40 7141 7154
8. Y. Song W. Chen D. Kang Q. Zhang P. Zhan X. Liu Old friends in new guise: exploiting privileged structures for scaffold re-evolution/refining Comb. Chem. High Throughput Screening 2014 17 6 536 553
9. R. Anand K. D. Gill A. A. Mahdi Therapeutics of Alzheimer's disease: Past, present and future Neuropharmacology 2014 76 Pt A 27 50
10. H. Zheng L. M. Weiner O. Bar-Am S. Epsztejn Z. I. Cabantchik A. Warshawsky M. B. Youdim M. Fridkin Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases Bioorg. Med. Chem. 2005 13 3 773 783
11. M. B. Youdim G. Stephenson D. Ben Shachar Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28 Ann. N. Y. Acad. Sci. 2004 1012 306 325
12. D. B. Shachar N. Kahana V. Kampel A. Warshawsky M. B. Youdim Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lesion in rats Neuropharmacology 2004 46 2 254 263
13. Y. Avramovich-Tirosh T. Amit O. Bar-Am H. Zheng M. Fridkin M. B. Youdim Therapeutic targets and potential of the novel brain-permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease J. Neurochem. 2007 100 2 490 502
14. O. Weinreb S. Mandel O. Bar-Am M. Yogev-Falach Y. Avramovich-Tirosh T. Amit M. B. Youdim Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs Neurotherapeutics 2009 6 1 163 174
15. S. Gal M. Fridkin T. Amit H. Zheng M. B. Youdim M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease J. Neural Transm., Suppl. 2006 70 447 456
16. P. J. Crouch K. J. Barnham Therapeutic redistribution of metal ions to treat Alzheimer's disease Acc. Chem. Res. 2012 45 9 1604 1611
17. P. Zhan X. Liu Rationally designed multitarget anti-HIV agents Curr. Med. Chem. 2013 20 13 1743 1758
18. P. Zhan X. Liu Designed multiple ligands: an emerging anti-HIV drug discovery paradigm Curr. Pharm. Des. 2009 15 16 1893 1917
19. L. Wang G. Esteban M. Ojima O. M. Bautista-Aguilera T. Inokuchi I. Moraleda I. Iriepa A. Samadi M. B. Youdim A. Romero E. Soriano R. Herrero A. P. Fernández R.-M. Murillo J. Marco-Contelles M. Unzeta Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease Eur. J. Med. Chem. 2014 80 543 561
20. I. Cacciatore E. Fornasari L. Baldassarre C. Cornacchia S. Fulle E. S. Di Filippo T. Pietrangelo F. Pinnen A Potent (R)-alpha-bis-lipoyl derivative containing 8-hydroxyquinoline scaffold: synthesis and biological evaluation of its neuroprotective capabilities in SH-SY5Y human neuroblastoma cells Pharmaceuticals 2013 6 1 54 69
21. I. Cacciatore C. Cornacchia E. Fornasari L. Baldassarre F. Pinnen P. Sozio A. Di Stefano L. Marinelli A. Dean S. Fulle E. S. Di Filippo R. M. La Rovere A. Patruno A. Ferrone V. Di Marco A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation ChemMedChem 2013 8 11 1818 1829
22. B. Ghosh T. Antonio M. E. Reith A. K. Dutta Discovery of 4-(4-(2-((5-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease J. Med. Chem. 2010 53 5 2114 2125
23. S. Gogoi T. Antonio S. Rajagopalan M. Reith J. Andersen A. K. Dutta Dopamine D2/D3 agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease ChemMedChem 2011 6 6 991 995
24. F. Mao J. Yan J. Li X. Jia H. Miao Y. Sun L. Huang X. Li New Multi-Target-Directed Small Molecules Against Alzheimer's Disease: The Combination of Resveratrol and Clioquinol Org. Biomol. Chem. 2014 12 31 5936 5944
25. A. Martirosyan S. Leonard X. Shi B. Griffith P. Gannett J. Strobl Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells J. Pharmacol. Exp. Ther. 2006 317 2 546 552
26. S. H. Chan C. H. Chui S. W. Chan S. H. Kok D. Chan M. Y. Tsoi P. H. Leung A. K. Lam A. S. Chan K. H. Lam J. C. Tang Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents ACS Med. Chem. Lett. 2012 4 2 170 174
27. V. Moret Y. Laras T. Cresteil G. Aubert D. Q. Ping C. Di M. Barthélémy-Requin C. Béclin V. Peyrot D. Allegro A. Rolland F. De Angelis E. Gatti P. Pierre L. Pasquini E. Petrucci U. Testa J. L. Kraus Discovery of a new family of bis-8-hydroxyquinoline substituted benzylamines with pro-apoptotic activity in cancer cells: synthesis, structure-activity relationship, and action mechanism studies Eur. J. Med. Chem. 2009 44 2 558 567
28. C. Bruyère S. Madonna G. Van Goietsenoven V. Mathieu J. Dessolin J. L. Kraus F. Lefranc R. Kiss JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation Transl. Oncol. 2011 4 3 126 137
29. S. Madonna C. Béclin Y. Laras V. Moret A. Marcowycz D. Lamoral-Theys J. Dubois M. Barthelemy-Requin G. Lenglet S. Depauw T. Cresteil G. Aubert V. Monnier R. Kiss M. H. David-Cordonnier J. L. Kraus Structure-activity relationships and mechanism of action of antitumor bis 8-hydroxyquinoline substituted benzylamines Eur. J. Med. Chem. 2010 45 2 623 638
30. S. Madonna A. Marcowycz D. Lamoral-Theys G. Van Goietsenoven J. Dessolin C. Pirker S. Spiegl-Kreinecker C.-A. Biraboneye W. Berger R. Kiss Bis-8-hydroxyquinoline and bis-8-hydroxyquinaldine N-substituted amines: a single methyl group structural difference between the two heterocycles, which modulates the antiproliferative effects J. Heterocycl. Chem. 2010 47 3 719 723
31. G. Lescoat S. Léonce A. Pierré L. Gouffier F. Gaboriau Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures Chem.-Biol. Interact. 2012 195 2 165 172
32. A. Y. Shaw C. Y. Chang M. Y. Hsu P. J. Lu C. N. Yang H. L. Chen C. W. Lo C. W. Shiau M. K. Chern Synthesis and structure-activity relationship study of 8-hydroxyquinoline-derived Mannich bases as anticancer agents Eur. J. Med. Chem. 2010 45 7 2860 2867
33. L. B. de O Freitas T. F. Borgati R. P. de Freitas A. L. Ruiz G. M. Marchetti J. E. de Carvalho E. F. da Cunha T. C. Ramalho R. B. Alves Synthesis and antiproliferative activity of 8-hydroxyquinoline derivatives containing a 1,2,3-triazole moiety Eur. J. Med. Chem. 2014 84 595 604
34. I. Sosič B. Mirković K. Arenz B. Stefane J. Kos S. Gobec Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives J. Med. Chem. 2013 56 2 521 533
35. S. Bhat J. S. Shim F. Zhang C. R. Chong J. O. Liu Substituted oxines inhibit endothelial cell proliferation and angiogenesis Org. Biomol. Chem. 2012 10 15 2979 2992
36. F. Sliman M. Blairvacq E. Durieu L. Meijer J. Rodrigo D. Desmaële Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase Bioorg. Med. Chem. Lett. 2010 20 9 2801 2805
37. A. C. Good J. Liu B. Hirth G. Asmussen Y. Xiang H. P. Biemann K. A. Bishop T. Fremgen M. Fitzgerald T. Gladysheva A. Jain K. Jancsics M. Metz A. Papoulis R. Skerlj J. D. Stepp R. R. Wei Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design J. Med. Chem. 2012 55 6 2641 2648
38. D. J. Richard R. Lena T. Bannister N. Blake W. E. Pierceall N. E. Carlson C. E. Keller M. Koenig Y. He D. Minond J. Mishra M. Cameron T. Spicer P. Hodder M. H. Cardone Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker Bioorg. Med. Chem. 2013 21 21 6642 6649
39. M. O. Oyewumi A. Alazizi S. Liva L. Lin W. J. Geldenhuys Screening and identification of novel compounds with potential anti-proliferative effects on gallium-resistant lung cancer through an AXL kinase pathway Bioorg. Med. Chem. Lett. 2014 24 18 4553 4556
40. C. Loenarz C. J. Schofield Expanding chemical biology of 2-oxoglutarate oxygenases Nat. Chem. Biol. 2008 4 3 152 156
41. R. J. Hopkinson A. Tumber C. Yapp R. Chowdhury W. Aik K. H. Che X. S. Li J. B. L. Kristensen O. King M. C. Chan K. K. Yeoh H. Choi L. J. Walport C. C. Thinnes J. T. Bush C. Lejeune A. M. Rydzik N. R. Rose E. A. L. Bagg M. A. McDonough T. Krojer W. W. Yue S. S. Ng L. Olsen P. Brennan U. Oppermann S. Muller-Knapp R. J. Klose P. J. Ratcliffe C. J. Schofield A. Kawamura 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation Chem. Sci. 2013 4 3110 3117
42. O. N. King X. S. Li M. Sakurai A. Kawamura N. R. Rose S. S. Ng A. M. Quinn G. Rai B. T. Mott P. Beswick R. J. Klose U. Oppermann A. Jadhav T. D. Heightman D. J. Maloney C. J. Schofield A. Simeonov Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors PLoS One 2010 5 11 e15535
43. W. Aik M. Demetriades M. K. Hamdan E. A. Bagg K. K. Yeoh C. Lejeune Z. Zhang M. A. McDonough C. J. Schofield Structural basis for inhibition of the fat mass and obesity associated protein (FTO) J. Med. Chem. 2013 56 9 3680 3688
44. R. Schiller G. Scozzafava A. Tumber J. R. Wickens J. T. Bush G. Rai C. Lejeune H. Choi T. L. Yeh M. C. Chan B. T. Mott J. S. McCullagh D. J. Maloney C. J. Schofield A. Kawamura A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1 ChemMedChem 2014 9 3 566 571
45. C. H. Arrowsmith C. Bountra P. V. Fish K. Lee M. Schapira Epigenetic protein families: a new frontier for drug discovery Nat. Rev. Drug Discovery 2012 11 5 384 400
46. C. C. Thinnes K. S. England A. Kawamura R. Chowdhury C. J. Schofield R. J. Hopkinson Targeting histone lysine demethylases-Progress, challenges, and the future Biochim. Biophys. Acta 2014 S1874 10.1016/j.bbagrm.2014.05.009
47. D. Rotili S. Tomassi M. Conte R. Benedetti M. Tortorici G. Ciossani S. Valente B. Marrocco D. Labella E. Novellino A. Mattevi L. Altucci A. Tumber C. Yapp O. N. King R. J. Hopkinson A. Kawamura C. J. Schofield A. Mai Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities J. Med. Chem. 2014 57 1 42 55
48. G. Rai, A. Kawamura, A. Tumber, Y. Liang, J. L. Vogel, J. H. Arbuckle, N. R. Rose, T. S. Dexheimer, T. L. Foley, O. N. King, A. Quinn, B. T. Mott, C. J. Schofield, U. Oppermann, A. Jadhav, A. Simeonov, T. M. Kristie and D. J. Maloney, Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity, SourceProbe Reports from the NIH Molecular Libraries Program [Internet], National Center for Biotechnology Information (US), Bethesda (MD), 2010-2012 Dec 17, updated 16 Sep 2013
49. X. J. Wang L. B. Si Advances on hypoxia inducible factor-1 Chin. Med. J. 2013 126 18 3567 3571
50. H. Moon S. Han H. Park J. Choe Crystal structures of human FIH-1 in complex with quinol family inhibitors Mol. Cells 2010 29 5 471 474
51. J. A. Jacobsen J. L. Fullagar M. T. Miller S. M. Cohen Identifying chelators for metalloprotein inhibitors using a fragment-based approach J. Med. Chem. 2011 54 2 591 602
52. K. Hanaya M. Suetsugu S. Saijo I. Yamato S. Aoki Potent inhibition of dinuclear zinc(ii) peptidase, an aminopeptidase from Aeromonas proteolytica, by 8-quinolinol derivatives: inhibitor design based on Zn2+ fluorophores, kinetic, and X-ray crystallographic study J. Biol. Inorg. Chem. 2012 17 4 517 529
53. K. Mekouar J. F. Mouscadet D. Desmaële F. Subra H. Leh D. Savouré C. Auclair J. d'Angelo Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells J. Med. Chem. 1998 41 15 2846 2857
54. S. M. Cohen, A. Agrawal, J. Desoto, Y. Pommier and K. Maddali, Preparation of raltegravir-chelator derivatives as HIV integrase inhibitors, PCT Int. Appl., WO 2012106534 A2, 2012, p. 20120809
55. E. Serrao B. Debnath H. Otake Y. Kuang F. Christ Z. Debyser N. Neamati Fragment-Based Discovery of 8-Hydroxyquinoline Inhibitors of the HIV-1 Integrase-Lens Epithelium-Derived Growth Factor/p75 (IN-LEDGF/p75) Interaction J. Med. Chem. 2013 56 6 2311 2322
56. R. Musiol J. Jampilek V. Buchta L. Silva H. Niedbala B. Podeszwa A. Palka K. Majerz-Maniecka B. Oleksyn J. Polanski Antifungal properties of new series of quinoline derivatives Bioorg. Med. Chem. 2006 14 10 3592 3598
57. M. J. McKay A. R. Carroll R. J. Quinn Perspicamides A and B, quinolinecarboxylic acid derivatives from the Australian ascidian Botrylloides perspicuum J. Nat. Prod. 2005 68 12 1776 1778
58. A. K. Pandey R. Sharma R. Shivahare A. Arora N. Rastogi S. Gupta P. M. Chauhan Synthesis of perspicamide A and related diverse analogues: their bioevaluation as potent antileishmanial agents J. Org. Chem. 2013 78 4 1534 1546
59. A. F. Eweas G. Allam A. S. Abuelsaad A. H. Alghamdi I. A. Maghrabi Design, synthesis, anti-schistosomal activity and molecular docking of novel 8-hydroxyquinoline-5-sufonyl 1,4-diazepine derivatives Bioorg. Chem. 2013 46 17 25
60. G. C. Capodagli W. G. Sedhom M. Jackson K. A. Ahrendt S. D. Pegan A noncompetitive inhibitor for Mycobacterium tuberculosis's class IIa fructose 1,6-bisphosphate aldolase Biochemistry 2014 53 1 202 213
61. D. Caglič M. C. Krutein K. M. Bompiani D. J. Barlow G. Benoni J. C. Pelletier A. B. Reitz L. L. Lairson K. L. Houseknecht G. R. Smith T. J. Dickerson Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain J. Med. Chem. 2014 57 3 669 676
62. N. Audic G. Potier N. A. Sasaki New 2,3-diaminopropionic acid inhibitors of AGE and ALE formation Org. Biomol. Chem. 2013 11 5 773 780
63. H. P. Zeng T. T. Wang X. H. Ouyang Y. D. Zhou H. L. Jing G. Z. Yuan D. F. Chen S. H. Du H. Li J. H. Zhou 8-Hydroxyquinoline derivatives induce the proliferation of rat mesenchymal stem cells (rMSCs) Bioorg. Med. Chem. 2006 14 16 5446 5450
64. S. Ariyasu A. Sawa A. Morita K. Hanaya M. Hoshi I. Takahashi B. Wang S. Aoki Design and synthesis of 8-hydroxyquinoline-based radioprotective agents Bioorg. Med. Chem. 2014 22 15 3891 3905
65. Y. Chen H. Wang L. Wan Y. Bian J. Jiang 8-Hydroxyquinoline-substituted boron-dipyrromethene compounds: synthesis, structure, and OFF-ON-OFF type of pH-sensing properties J. Org. Chem. 2011 76 10 3774 3781
66. G. Farruggia S. Iotti M. Lombardo C. Marraccini D. Petruzziello L. Prodi M. Sgarzi C. Trombini N. Zaccheroni Microwave assisted synthesis of a small library of substituted N,N′-bis((8-hydroxy-7-quinolinyl)methyl)-1,10-diaza-18-crown-6 ethers J. Org. Chem. 2010 75 18 6275 6278
67. J. A. González-Vera E. Luković B. Imperiali Synthesis of red-shifted 8-hydroxyquinoline derivatives using click chemistry and their incorporation into phosphorylation chemosensors J. Org. Chem. 2009 74 19 7309 7314
68. J. P. Heiskanen W. A. Omar M. K. Ylikunnari K. M. Haavisto M. J. Juan O. E. Hormi Synthesis of 4-alkoxy-8-hydroxyquinolines J. Org. Chem. 2007 72 3 920 922
69. F. Babudri A. Cardone C. T. Cioffi G. M. Farinola F. Naso R. Ragni A straightforward methodology for the introduction of aryl and vinyl substituents in the 5 or 7 position of 8-hydroxyquinoline Synthesis 2006 8 1325 1332